Immunotherapy in small cell lung cancer: one step at a time: a narrative review

Chemotherapy with or without radiotherapy has been the standard of care for many years for patients with small cell lung cancer (SCLC). Despite exceptionally high responses (up to 80%) with chemotherapy, the majority of patients relapse rapidly within weeks to months after treatment completion. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumoulin, Daphne W., Dingemans, Anne-Marie C., Aerts, Joachim G. J. V., Remon, Jordi, De Ruysscher, Dirk K. M., Hendriks, Lizza E. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264327/
https://www.ncbi.nlm.nih.gov/pubmed/34295691
http://dx.doi.org/10.21037/tlcr-20-630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264327/
https://www.ncbi.nlm.nih.gov/pubmed/34295691
http://dx.doi.org/10.21037/tlcr-20-630

Ejemplares similares